Fresenius (ETR:FRE) target price increased to 81.00EUR, reported today by Commerzbank AG
- Updated: September 19, 2016
Just yesterday Fresenius (ETR:FRE) traded 0.00% even at 70.00EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. With the last stock close up 0.00% relative to the two hundred day average, compared to the S&P 500 Index which has fallen -0.01% over the same period. Volume of trade was held steady, with 0 shares of FRE changing hands on par with the typical 0 shares..
In an issued report on Monday September 19 2016 Commerzbank AG upped the target price of Fresenius (ETR:FRE) from 0EUR to 81EUR reporting a possible upsideof 0.16%.
Recent Performance Graphic:
Fresenius has a one-year low of 0.00EUR and a 52 week high of 0.00EUR . Fresenius’s market capitalization is currently 0.0 EUR.
About Fresenius (ETR:FRE)
Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments include Fresenius Medical Care; Fresenius Kabi; Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment provides dialysis care and dialysis products for patients with chronic kidney failure. The Fresenius Kabi segment is engaged in provision of intravenously administered drugs (IV drugs), infusion therapies, and clinical nutrition and outpatient care. The Fresenius Helios segment is a private hospital operator and operates 72 clinics. The Fresenius Vamed segment provides engineering and services for hospitals and other health care facilities internationally.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.